Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression

References

• Anzenbacher P, Anzenbacherová E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737–47
   PubMed Web of Science ®Google Scholar
• Benhamou Y. (2006). Treatment algorithm for chronic hepatitis B in HIV-infected patients. J Hepatol 44:90–4
   Web of Science ®Google Scholar
• Curk T, Demsar J, Xu Q, et al. (2005). Microarray data mining with visual programming. Bioinformatics 21:396–8
   PubMedGoogle Scholar
• De Clercq E, Holy A. (2005). Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 4:928–40
   PubMed Web of Science ®Google Scholar
• De Clercq E, Andrei G, Balzarini J, et al. (2005). Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. Nucleosides Nucleotides Nucleic Acids 24:331–41
   PubMed Web of Science ®Google Scholar
• Delaney WE, Ray AS, Yang H, et al. (2006). Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus. Antimicrob Agents Chemother 50:2471–7
   PubMed Web of Science ®Google Scholar
• Demsar J, Zupan B, Leban G. (2004). Orange: from experimental machine learning to interactive data mining, White Paper, Faculty of Computer and Information Science, University of Ljubljana. Available at: http://www.ailab.si/orange [last accessed 14 Aug 2013]
   Google Scholar
• FDA. (2011). Viral hepatitis therapies. Available at: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/ucm151494.htm [last accessed 21 Sept 2013]
   Google Scholar
• Gnerre C, Schuster GU, Roth A, et al. (2005). LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver. J Lipid Res 46:1633–42
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (1995). Human cytochrome P450 enzymes. In: Ortiz de Montellano PR, ed. Cytochrome P450: structure, mechanisms and biochemistry. New York: Plenum, 473–535
   Google Scholar
• Gutala RV, Reddy PH. (2004). The use of real-time PCR analysis in a gene expression study of Alzheimer’s disease post-mortem brains. J Neurosci Methods 132:101–7
   PubMedGoogle Scholar
• Kearney BP, Flaherty JF, Shah J. (2004). Tenofovir disoproxil fumarate; clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 43:595–612
   PubMed Web of Science ®Google Scholar
• Kearney BP, Reul T, Coleman R, et al. (2000). Pharmacokinetics of adefovir dipivoxil (ADV) in combination with saquinavir (SQV), indinavir (IDV), efavirenz (EFV), delavirdine (DLV), didanosine (ddI), or lamivudine (3tc) in normal volunteers. Conf Retroviruses Opportunistic Infect 7:91 (abstract no 86)
   Google Scholar
• Nekvindová J, Masek V, Veinlichová A, et al. (2006). Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir. Xenobiotica 36:1165–77
   PubMed Web of Science ®Google Scholar
• Nelson DR. (2009). The Cytochrome P450 Homepage. Human Genomics 4:59–65
   PubMedGoogle Scholar
• Nunez M, Soriano V. (2005). Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis 5:374–82
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. (2001). A new mathematical model for relative quantification real-time RT-PCR. Nucleic Acids Res 29:e45
   PubMedGoogle Scholar
• Rezen T, Fon Tacer K, Kuzman D, et al. (2008). The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism. BMC Genomics, 9, 76. List of genes present on the Sterolgene v0 cDNA microarray. Available at: http://www.biomedcentral.com/content/supplementary/1471-2164-9-76-S1.pdf [last accessed 13 Sept 2013]
   Google Scholar
• Rezen T, Tamasi V, Lövgren-Sandblom A, et al. (2009). Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers. BMC Genomics 10:384
   PubMedGoogle Scholar
• WHO. (2013a). Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 1. HIV infections – drug therapy. 2. HIV infections – prevention and control. 3. Anti-Retroviral agents – therapeutic use. 4. Guideline. ISBN 978 92 4 150572 7. Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf [last accessed 19 Sept 2013]
   Google Scholar
• WHO. (2013b). HIV/AIDS. Fact sheet N°360. Updated October 2013. Available at: http://www.who.int/mediacentre/factsheets/fs360/en/index.html [last accessed 9 Nov 2013]
   Google Scholar
• WHO. (2013c). Hepatitis B. Fact sheet N°204. Updated July 2013. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/index.html [last accessed 19 Sept 2013]
   Google Scholar
• Yang D, Wu L, Hwang YS, et al. (2001). Expression of the REB transcriptional activator in rice grains improves the yield of recombinant proteins whose genes are controlled by a Reb-responsive promoter. Proc Natl Acad Sci USA 98:11438–43
   PubMed Web of Science ®Google Scholar
• Zhang WX, Lai V, Mutimer D, Mirza D. (2006). Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatobiliary Pancreat Dis Int 5:154–6
   PubMedGoogle Scholar